WAS
VSTM icon

WESPAC Advisors SoCal’s Verastem VSTM Stock Holding History

WESPAC Advisors SoCal’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,667
Closed -$43K – 82
2020
Q4 		$43K Hold
1,667
– – 0.02% 74
2020
Q3 		$28K Hold
1,667
– – 0.01% 73
2020
Q2 		$29K Buy
+1,667
New +$44.1K 0.01% 79

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

WESPAC Advisors SoCal's VSTM Position: Q1 2021 in Review

WESPAC Advisors SoCal sold out of Verastem (VSTM) in Q1 2021, closing a stake of 1,667 shares — an estimated $43K sold.

WESPAC Advisors SoCal first reported a position in VSTM in Q2 2020 and held it in 3 quarters. The position peaked at $43K in Q4 2020. 135 funds tracked by Wall St. Rank hold VSTM as of Q1 2021.

  • WESPAC Advisors SoCal reported no remaining Verastem position as of Q1 2021 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 1,667 Verastem shares in Q1 2021, an estimated $43K.
  • WESPAC Advisors SoCal first reported a position in Verastem in Q2 2020 and held it in 3 quarters.
  • WESPAC Advisors SoCal's Verastem position peaked at $43K in Q4 2020.
  • 135 funds tracked by Wall St. Rank held Verastem as of Q1 2021.

Based on WESPAC Advisors SoCal's 13F filing for Q1 2021, filed 30 Apr 2021.